SIM
ARIA

Strategic Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Strategic Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,935
Closed -$88K – 137
2014
Q2 		$88K Buy
+13,935
New +$95.8K 0.02% 104
2014
Q1 		– Sell
-11,804
Closed -$81K – 84
2013
Q4 		$81K Buy
+11,804
New +$63.7K 0.02% 67

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Strategic Investment Management's ARIA Position: Q3 2014 in Review

Strategic Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2014, closing a stake of 13,935 shares — an estimated $88K sold.

Strategic Investment Management first reported a position in ARIA in Q4 2013 and held it in 2 quarters. The position peaked at $88K in Q2 2014. 169 funds tracked by Wall St. Rank hold ARIA as of Q3 2014.

  • Strategic Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Strategic Investment Management sold 13,935 Ariad Pharmaceuticals Inc shares in Q3 2014, an estimated $88K.
  • Strategic Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 2 quarters.
  • Strategic Investment Management's Ariad Pharmaceuticals Inc position peaked at $88K in Q2 2014.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2014.

Based on Strategic Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.